$BFYW
Better For You Wellness, Inc. Stock $bfyw

$bfyw Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-K Financial Statement

#000157587224000990 Filed on September 10, 2024

Income Statement

Concept	2024 Q3	2024 Q1	2024
Revenue	$5.840K	$5.670K	$10.32K
YoY Change	224.44%	135.27%	-9.58%
Cost Of Revenue	$3.657K	$3.460K	$5.352K
YoY Change	859.84%	14.19%	-70.93%
Gross Profit	$2.187K	$2.210K	$4.969K
YoY Change	53.69%	-456.45%	-171.04%
Gross Profit Margin	37.45%	38.98%	48.15%
Selling, General & Admin	$199.5K	$205.6K	$1.013M
YoY Change	-29.1%	-82.14%	-16.59%
% of Gross Profit	9122.22%	9304.52%	20392.47%
Research & Development	$0.00		$0.00
YoY Change
% of Gross Profit	0.0%		0.0%
Depreciation & Amortization	$1.356K	$580.00	$1.156K
YoY Change	578.0%	190.0%	48.97%
% of Gross Profit	62.0%	26.24%	23.26%
Operating Expenses	$199.5K	$205.6K	$2.242M
YoY Change	-56.83%	-82.14%	-32.78%
Operating Profit	-$197.3K	-$203.4K	-$2.237M
YoY Change	-57.17%	-82.34%	-33.07%
Interest Expense	-$107.8K	-$35.40K	-$135.6K
YoY Change	322.62%	-36.72%	-26.47%
% of Operating Profit
Other Income/Expense, Net	-$105.8K		-$216.5K
YoY Change	314.94%		17.41%
Pretax Income	-$303.2K	-$822.3K	-$2.454M
YoY Change	-37.65%	-31.93%	-30.43%
Income Tax
% Of Pretax Income
Net Earnings	-$303.1K	-$822.3K	-$2.454M
YoY Change	-37.65%	-31.93%	-30.43%
Net Earnings / Revenue	-5190.86%	-14502.47%	-23778.43%
Basic Earnings Per Share	$0.00		-$0.01
Diluted Earnings Per Share	$0.00	$0.00	-$0.01
COMMON SHARES
Basic Shares Outstanding	507.8M	419.2M	413.5M
Diluted Shares Outstanding	507.8M		413.5M

Balance Sheet

Concept	2024 Q3	2024 Q1	2024
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.000K	$1.720K	$1.720K
YoY Change	-6.54%	-87.51%	-87.51%
Cash & Equivalents	$2.999K	$1.716K
Short-Term Investments
Other Short-Term Assets	$13.93K	$4.630K	$4.630K
YoY Change	39.02%	-74.96%	-74.96%
Inventory	$56.09K	$55.42K	$55.42K
Prepaid Expenses	$13.93K	$4.634K
Receivables	$8.262K	$2.634K	$2.630K
Other Receivables	$0.00	$5.152K	$5.160K
Total Short-Term Assets	$81.29K	$69.55K	$69.55K
YoY Change	77.78%	100.41%	100.37%
LONG-TERM ASSETS
Property, Plant & Equipment	$3.053K	$5.260K	$151.7K
YoY Change	163.42%	240.01%	9687.74%
Goodwill		$0.00
YoY Change		-100.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$117.6K	$151.7K	$151.7K
YoY Change	-84.94%	-74.07%	-74.07%
TOTAL ASSETS
Total Short-Term Assets	$81.29K	$69.55K	$69.55K
Total Long-Term Assets	$117.6K	$151.7K	$151.7K
Total Assets	$198.9K	$221.3K	$221.3K
YoY Change	-75.93%	-64.3%	-64.3%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.040M	$601.5K	$767.3K
YoY Change	44.66%	53.9%	69.84%
Accrued Expenses	$69.81K	$65.77K	$65.77K
YoY Change	-5.16%
Deferred Revenue
YoY Change
Short-Term Debt	$1.348M	$1.216M	$1.216M
YoY Change	47.53%	36.94%	36.94%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$2.720M	$2.135M	$2.135M
YoY Change	39.09%	24.15%	24.15%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
Other Long-Term Liabilities	$44.74K	$80.69K	$80.69K
YoY Change	-63.46%
Total Long-Term Liabilities	$44.74K	$80.69K	$80.69K
YoY Change	-63.46%	3528.1%	3534.68%
TOTAL LIABILITIES
Total Short-Term Liabilities	$2.720M	$2.135M	$2.135M
Total Long-Term Liabilities	$44.74K	$80.69K	$80.69K
Total Liabilities	$2.764M	$2.215M	$2.215M
YoY Change	33.05%	28.68%	28.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$9.102M	-$8.530M
YoY Change	24.52%	40.39%
Common Stock	$50.78K	$41.95K
YoY Change	21.13%	3.84%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.565M	-$1.994M	-$1.994M
YoY Change
Total Liabilities & Shareholders Equity	$198.9K	$221.3K	$221.3K
YoY Change	-75.93%	-64.3%	-64.3%

Cashflow Statement

Concept	2024 Q3	2024 Q1	2024
OPERATING ACTIVITIES
Net Income	-$303.1K	-$822.3K	-$2.454M
YoY Change	-37.65%	-31.93%	-30.43%
Depreciation, Depletion And Amortization	$1.356K	$580.00	$1.156K
YoY Change	578.0%	190.0%	48.97%
Cash From Operating Activities	-$21.20K	-$198.5K	-$423.3K
YoY Change	-68.62%	249.38%	-48.23%
INVESTING ACTIVITIES
Capital Expenditures	$490.00	$0.00	$0.00
YoY Change			-100.0%
Acquisitions			$0.00
YoY Change			-100.0%
Other Investing Activities		$0.00	$0.00
YoY Change		-100.0%	-100.0%
Cash From Investing Activities	-$490.00	$0.00	$0.00
YoY Change		-100.0%	-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	22.66K	199.8K	411.3K
YoY Change	-57.25%	171.82%	-50.47%
NET CHANGE
Cash From Operating Activities	-21.20K	-198.5K	-423.3K
Cash From Investing Activities	-490.0	0.000	0.000
Cash From Financing Activities	22.66K	199.8K	411.3K
Net Change In Cash	970.0	1.340K	-12.06K
YoY Change	-106.66%	-87.37%	-391.87%
FREE CASH FLOW
Cash From Operating Activities	-$21.20K	-$198.5K	-$423.3K
Capital Expenditures	$490.00	$0.00	$0.00
Free Cash Flow	-$21.69K	-$198.5K	-$423.3K
YoY Change	-67.9%	249.38%	-48.38%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2024Q1	us-gaap	Notes Payable Current Related Party Type Extensible Enumeration NotesPayableCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2023Q1	us-gaap	Notes Payable Current Related Party Type Extensible Enumeration NotesPayableCurrentRelatedPartyTypeExtensibleEnumeration	http://fasb.org/us-gaap/2023#RelatedPartyMember
CY2024	dei	Amendment Flag AmendmentFlag	false
CY2024	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2024	dei	Entity Central Index Key EntityCentralIndexKey	0001852707
CY2024	dei	Entity Address State Or Province EntityAddressStateOrProvince	OH
CY2024	dei	Document Type DocumentType	10-K
CY2024	dei	Document Annual Report DocumentAnnualReport	true
CY2024	dei	Document Period End Date DocumentPeriodEndDate	2024-02-28
CY2024	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--02-28
CY2024	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2024	dei	Document Transition Report DocumentTransitionReport	false
CY2024	dei	Entity File Number EntityFileNumber	000-56262
CY2024	dei	Entity Registrant Name EntityRegistrantName	BETTER FOR YOU WELLNESS, INC.
CY2024	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2024	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2903933
CY2024	dei	Entity Address Address Line1 EntityAddressAddressLine1	1349 East Broad Street
CY2024	dei	Entity Address City Or Town EntityAddressCityOrTown	Columbus
CY2024	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	43205
CY2024	dei	City Area Code CityAreaCode	1 (888)
CY2024	dei	Local Phone Number LocalPhoneNumber	287-7555
CY2024	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2024	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2024	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2024	dei	Entity Small Business EntitySmallBusiness	true
CY2024	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2024	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2024	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2024	dei	Entity Shell Company EntityShellCompany	false
CY2024	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022Q3	dei	Entity Public Float EntityPublicFloat	11740000
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	507807233
CY2024	dei	Auditor Firm AuditorFirmId	1808
CY2024	dei	Auditor Name AuditorName	GBQ Partners LLC
CY2024	dei	Auditor Location AuditorLocation	Columbus, Ohio
CY2024Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1716
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13773
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2634
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1460
CY2024Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4634
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	18493
CY2024Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	5152
CY2023Q1	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	0
CY2024Q1	us-gaap	Inventory Net InventoryNet	55416
CY2023Q1	us-gaap	Inventory Net InventoryNet	979
CY2024Q1	us-gaap	Assets Current AssetsCurrent	69552
CY2023Q1	us-gaap	Assets Current AssetsCurrent	34705
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5260
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1547
CY2024Q1	us-gaap	Goodwill Goodwill	0
CY2023Q1	us-gaap	Goodwill Goodwill	583484
CY2024Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	146454
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	0
CY2024Q1	us-gaap	Assets Assets	221266
CY2023Q1	us-gaap	Assets Assets	619736
CY2024Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	601487
CY2023Q1	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	393777
CY2024Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	85823
CY2023Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	379759
CY2024Q1	us-gaap	Notes Payable Current NotesPayableCurrent	449287
CY2023Q1	us-gaap	Notes Payable Current NotesPayableCurrent	293000
CY2024Q1	us-gaap	Interest Payable Current InterestPayableCurrent	165843
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	60243
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	65765
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	0
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	766419
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	594804
CY2024Q1	us-gaap	Liabilities Current LiabilitiesCurrent	2134624
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1721583
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	80689
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	0
CY2024Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	80689
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0
CY2024Q1	us-gaap	Liabilities Liabilities	2215313
CY2023Q1	us-gaap	Liabilities Liabilities	1721583
CY2024Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000
CY2024Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000
CY2023Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	700000
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	700000
CY2023Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	700000
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	700000
CY2024Q1	us-gaap	Preferred Stock Value PreferredStockValue	70
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	70
CY2024Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	500000000
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	419509183
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	419509183
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	404014987
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	404014987
CY2024Q1	us-gaap	Common Stock Value CommonStockValue	41953
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	40403
CY2024Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	6493465
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4933281
CY2024Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-8529535
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-6075601
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1994047
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1101847
CY2024Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	221266
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	619736
CY2024	bfyw	Merchandise Sales Amount MerchandiseSalesAmount	10321
CY2023	bfyw	Merchandise Sales Amount MerchandiseSalesAmount	11414
CY2024	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	5352
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	18409
CY2024	us-gaap	Gross Profit GrossProfit	4969
CY2023	us-gaap	Gross Profit GrossProfit	-6995
CY2024	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	645617
CY2023	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	2121213
CY2024	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1013302
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	1214828
CY2024	bfyw	Impairment Loss Goodwill ImpairmentLossGoodwill	583484
CY2024	us-gaap	Operating Expenses OperatingExpenses	2242403
CY2023	us-gaap	Operating Expenses OperatingExpenses	3336041
CY2024	us-gaap	Operating Income Loss OperatingIncomeLoss	-2237434
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-3343036
CY2024	us-gaap	Interest Expense Other InterestExpenseOther	135586
CY2023	us-gaap	Interest Expense Other InterestExpenseOther	184389
CY2024	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-80914
CY2024	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-216500
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-184389
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2453934
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3527425
CY2024	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2024	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2024	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	413530726
CY2024	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	413530726
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	392643105
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	392643105
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	-365766
CY2023	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	834121
CY2023	us-gaap	Stock Issued During Period Value Purchase Of Assets StockIssuedDuringPeriodValuePurchaseOfAssets	550000
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3750
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities Net Of Adjustments StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments	64212
CY2023	bfyw	Common Shares Issued For Debt Settlement For Purchase Of Subsititary No Subsidiary Acquired This CommonSharesIssuedForDebtSettlementForPurchaseOfSubsititaryNoSubsidiaryAcquiredThis	17500
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1241373
CY2023	us-gaap	Adjustments To Additional Paid In Capital Mark To Market AdjustmentsToAdditionalPaidInCapitalMarkToMarket	30702
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	49686
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3527425
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1101847
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-1101847
CY2024	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	12790
CY2024	bfyw	Stock Issued During Period Value Settlement Of Debt StockIssuedDuringPeriodValueSettlementOfDebt	195000
CY2024	us-gaap	Deferred Compensation Arrangement With Individual Fair Value Of Shares Issued DeferredCompensationArrangementWithIndividualFairValueOfSharesIssued	331103
CY2024	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	614614
CY2024	bfyw	Deferred Share Based Compensation Shares Issuable In The Future For Conversion Value DeferredShareBasedCompensationSharesIssuableInTheFutureForConversionValue	351984
CY2024	bfyw	Preferred Stock Issuable For Asset Purchase In The Future Value PreferredStockIssuableForAssetPurchaseInTheFutureValue	56243
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2453934
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	-1994047
CY2024	us-gaap	Net Income Loss NetIncomeLoss	-2453934
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-3527425
CY2024	us-gaap	Share Based Compensation ShareBasedCompensation	627404
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	2121213
CY2024	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	15578
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	72478
CY2024	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	10333
CY2023	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	51667
CY2024	us-gaap	Depreciation And Amortization DepreciationAndAmortization	1156
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	776
CY2024	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	583484
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	0
CY2024	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	80914
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2024	bfyw	Amortization Of Debt Premium AmortizationOfDebtPremium	4790
CY2023	bfyw	Amortization Of Debt Premium AmortizationOfDebtPremium	0
CY2024	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1174
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1460
CY2024	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	3063
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-12127
CY2024	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-13859
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	0
CY2024	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	5152
CY2023	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	0
CY2024	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	207710
CY2023	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	15422
CY2024	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-105600
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	-60243
CY2024	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	389151
CY2023	us-gaap	Increase Decrease In Deferred Compensation IncreaseDecreaseInDeferredCompensation	379759
CY2024	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	0
CY2023	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-2555
CY2024	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-423344
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-817755
CY2024	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	6087
CY2024	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	0
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	2323
CY2024	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8410
CY2024	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5000
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	56640
CY2024	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	65000
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	558000
CY2024	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	403787
CY2023	us-gaap	Proceeds From Subordinated Short Term Debt ProceedsFromSubordinatedShortTermDebt	275500
CY2024	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	52500
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	0
CY2024	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	3750
CY2024	bfyw	Expenses Contributed To Capital ExpensesContributedToCapital	0
CY2023	bfyw	Expenses Contributed To Capital ExpensesContributedToCapital	49686
CY2024	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	411287
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	830296
CY2024	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-12057
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	4131
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13773
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	9642
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1716
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13773
CY2024	bfyw	Common Stock Issued For Acquisition Value CommonStockIssuedForAcquisitionValue	0
CY2023	bfyw	Common Stock Issued For Acquisition Value CommonStockIssuedForAcquisitionValue	550000
CY2024	us-gaap	Stock Issued1 StockIssued1	0
CY2023	us-gaap	Stock Issued1 StockIssued1	17500
CY2024	bfyw	Warrants Issued And Extended For Common Stock Issuance Costs Value WarrantsIssuedAndExtendedForCommonStockIssuanceCostsValue	0
CY2023	bfyw	Warrants Issued And Extended For Common Stock Issuance Costs Value WarrantsIssuedAndExtendedForCommonStockIssuanceCostsValue	30702
CY2024	bfyw	Discount On Notes Payable For Warrants DiscountOnNotesPayableForWarrants	0
CY2023	bfyw	Discount On Notes Payable For Warrants DiscountOnNotesPayableForWarrants	25197
CY2024	bfyw	Common Stock Issued For Settlement Of Debt CommonStockIssuedForSettlementOfDebt	195000
CY2023	bfyw	Common Stock Issued For Settlement Of Debt CommonStockIssuedForSettlementOfDebt	0
CY2024	bfyw	Preferred Stock Issuable For Asset Purchase In The Future Value PreferredStockIssuableForAssetPurchaseInTheFutureValue	56243
CY2023	bfyw	Preferred Stock Issuable For Asset Purchase In The Future Value PreferredStockIssuableForAssetPurchaseInTheFutureValue	0
CY2024	bfyw	Common Stock Issued For Settlement Of Deferred Compensation CommonStockIssuedForSettlementOfDeferredCompensation	333103
CY2023	bfyw	Common Stock Issued For Settlement Of Deferred Compensation CommonStockIssuedForSettlementOfDeferredCompensation	0
CY2024	bfyw	Common Stock Issuable For Settlement Of Deferred Compensation CommonStockIssuableForSettlementOfDeferredCompensation	351984
CY2023	bfyw	Common Stock Issuable For Settlement Of Deferred Compensation CommonStockIssuableForSettlementOfDeferredCompensation	0
CY2024	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt;text-indent: 0px;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Use of Estimates</div></div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; line-height: 12pt;text-indent: 0px;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: 12pt;text-indent: 0px;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities on the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. In the opinion of management, all adjustments necessary in order to make the financial statements not misleading have been included. Actual results could differ from those estimates.</div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: 12pt;text-indent: 0px;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: 12pt;text-indent: 0px;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">On an ongoing basis, the Company evaluates its estimates, including those related to the bad debt allowance, sales returns, stock-based compensation, goodwill, useful lives of property and equipment, income taxes, and contingent liabilities, among others. The Company bases its estimates on assumptions, both historical and forward looking, that are believed to be reasonable, the results of which form the basis for making judgments about the carrying amounts of assets and liabilities.</div></div>
CY2024Q1	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	1716
CY2023Q1	us-gaap	Other Cash Equivalents At Carrying Value OtherCashEquivalentsAtCarryingValue	13773
CY2024	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: 12pt;text-indent: 0px;"><br/></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: 12pt;text-indent: 0px;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Concentration of Credit Risks</div></div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: 12pt;text-indent: 0px;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div></div><div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: 12pt;text-indent: 0px;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">Financial instruments that potentially subject the Company to significant concentration of credit risk primarily consist of cash, cash equivalents, and accounts receivable. As of February 28, 2024, and 2023, the Company’s cash was held by financial institutions that management believes have acceptable credit. Accounts receivable<div style="letter-spacing: 0px; top: 0px;display:inline;">s</div> are typically unsecured. The risk with respect to accounts receivable is mitigated by regular credit evaluations that the Company performs on its distribution partners and its ongoing monitoring of outstanding balances.</div></div>
CY2024Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	2634
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1460
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2024Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0
CY2024Q1	us-gaap	Inventory Net InventoryNet	55416
CY2023Q1	us-gaap	Inventory Net InventoryNet	979
CY2024Q1	bfyw	Inventory Obsolescence InventoryObsolescence	0
CY2023Q1	bfyw	Inventory Obsolescence InventoryObsolescence	0
CY2023Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0
CY2024Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	0
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2024	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	2796
CY2023	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	19037
CY2024	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	0
CY2024	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: 12pt;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"> </div></div><br/></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: 12pt;"><div style="white-space:pre-line; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;">Reclassification of Prior Year Presentation </div></div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: 12pt;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; line-height: 12pt;"><div style="color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">Certain prior year amounts have been reclassified for consistency with the current year’s presentation. These reclassifications had no effect on the reported results of the operation.</div></div>
CY2024Q1	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	0
CY2022Q2	bfyw	Fair Market Value FairMarketValue	550000
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents	913
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Inventory BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory	12995
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets	13908
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable	2365
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt	2454
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther	537
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities	36
CY2022Q2	bfyw	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Notes Payable Related Party BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesNotesPayableRelatedParty	35000
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities	40392
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	-26484
CY2022Q2	us-gaap	Business Acquisitions Purchase Price Allocation Subsequent Years Remaining Adjustments BusinessAcquisitionsPurchasePriceAllocationSubsequentYearsRemainingAdjustments	-557000
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet	-583484
CY2024	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	557000
CY2024	us-gaap	Goodwill Other Increase Decrease GoodwillOtherIncreaseDecrease	583484
CY2023Q4	bfyw	Asset Acquisition Equipment AssetAcquisitionEquipment	4869
CY2023Q4	bfyw	Asset Acquistion Equipment Inventory AssetAcquistionEquipmentInventory	51374
CY2023Q4	bfyw	Asset Acquisition Aggregate Assets Acquired AssetAcquisitionAggregateAssetsAcquired	56243
CY2024	bfyw	Disclosure In Entirety Of Convertible Note DisclosureInEntiretyOfConvertibleNote	<div style="margin: 0in 0in 0.0001pt; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;">Note 7 - Convertible Notes Payable</div></div></div> <div style="margin: 0in 0in 0.0001pt; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; white-space: pre-wrap; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;white-space:pre-wrap;"> </div></div> <table cellpadding="0" cellspacing="0" style="text-align:start; width:100%; font-family:'Times New Roman'; font-size:10pt; border-spacing:0px; border-collapse:collapse; margin-bottom:0.0001pt; margin-top:0in"> <tr style="vertical-align:top; padding-bottom:0.0001pt; padding-top:0in"> <td style="width: 0in; overflow-wrap: break-word; vertical-align: top; font-family: "Times New Roman", Times, serif;"></td> <td style="width: 0.5in; vertical-align: top; overflow-wrap: break-word; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;">(A)</div></div> </td> <td style="text-align: justify; vertical-align: top; overflow-wrap: break-word; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; text-indent: 0px; margin-bottom: 1em"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;">On April 12, 2022, the Company entered into a Securities Purchase Agreement with Mast Hill Fund, L.P., in which Mast Hill purchased a promissory note, with a principal amount of $310,000 for a purchase price of $279,000 (the "Note"). The Note bears an original issue discount of $31,000, <div style="letter-spacing: 0px; top: 0px;display:inline;">and</div> interest of 12% per year and had an original maturity date of April 12, 2023 (the "Maturity Date").<div style="letter-spacing: 0px; top: 0px;display:inline;"> </div></div><br/></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; text-indent: 0px; margin-bottom: 1em; margin-top: 1em"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"><div style="letter-spacing: 0px; top: 0px;display:inline;"></div></div><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;display:inline;">On June 7, 2022, the Company entered into a second Securities Purchase Agreement with Mast Hill Fund, L.P., Pursuant to the June 7, 2022 Security Purchase Agreement, Mast Hill purchased a promissory note, with a principal amount of $310,000 for a purchase price of $279,000 (the “Note”). The Note bears an original issue discount of $31,000, each bear interest of 12% per year and had an original maturity date of June 7, 2023 (the “Maturity Date”). </div><br/></div> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt; text-indent: 0px; margin-top: 1em"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;display:inline;">On September 18, 2023, the Company entered into an amendment of both promissory. The outstanding principal balance of the notes increased by $40,891 and $40,023, respectively. The interest rate on both notes has been increased to 18% as a result of the amendment, and the maturity date has been extended to September 13, 2024. Because the fair value of consideration issued was greater than 10% of the present value of the remaining cash flows under the modified notes, the transaction was treated as a debt extinguishment and reissuance of new debt instruments pursuant to the guidance of ASC 470-50. A loss on debt extinguishment was recorded of $80,914 on the consolidated statement of operations. There was no change in fair value of the debt instruments subsequent to the amendment date, since the extinguishment transaction occurred on September 18, 2023.</div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="margin: 0in 0in 0.0001pt; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; white-space: pre-wrap; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;white-space:pre-wrap;"> </div></div> <div style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;">The above notes are convertible into shares of the Company's common stock at conversion price of $0.037 per share, subject to adjustment as provided therein. The Company has the right to prepay the Note in full, including accrued but unpaid interest, without prepayment penalty provided an event of default, as defined therein, has not occurred. In the seven (7) trading days prior to any prepayment Mast Hill shall have the right to convert their Note into Common Stock of the Company in accordance with the terms of such Note. The Note contains events of defaults and certain negative covenants that are typical in the types of transactions contemplated by the Purchase Agreements.</div></div> <div style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; white-space: pre-wrap; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;white-space:pre-wrap;"> </div></div> <div style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;">Pursuant to the Purchase Agreements, the Company issued to Mast Hill 4,960,000 shares of the Company’s common stock (the “Commitment Shares”) as a condition to closing. Further, the Company entered into a Registration Rights Agreement (the “Registration Rights Agreement”) with Mast Hill, pursuant to which the Company is obligated to file a registration statement. On October 11, 2022, Mast Hill Fund agreed to extend the timeframes in section 2(a) of the Registration Rights Agreement dated April 12, 2022 until February 9, 2023, and to have the Registration Statement become effective on or before February 9, 2037.</div></div> <div style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; white-space: pre-wrap; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;white-space:pre-wrap;"> </div></div> <div style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"></div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); line-height: 12pt; letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;display:inline;">The total interest expense and accrued interest on both the Mast Hill Fund promissory notes were</div></div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"> $129,877 and $164,924 </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); line-height: 12pt; letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;display:inline;">respectively for the years ended February 28, 2024.</div></div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"></div></div> <div style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); line-height: 12pt; letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"></div><br/></div> <div style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); line-height: 12pt; letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;display:inline;">The total interest expense and accrued interest on both the Mast Hill Fund promissory notes were $60,244 and $60,243 respectively for the years ended February 28, 2023.</div></div><br/></div> <div style="margin: 0in 0in 0.0001pt; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; white-space: pre-wrap; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;white-space:pre-wrap;"> </div></div> <table cellpadding="0" cellspacing="0" style="text-align:start; width:100%; font-family:'Times New Roman'; font-size:10pt; border-spacing:0px; border-collapse:collapse; margin-bottom:0.0001pt; margin-top:0in"> <tr style="vertical-align:top; padding-bottom:0.0001pt; padding-top:0in"> <td style="width: 0in; overflow-wrap: break-word; vertical-align: top; font-family: "Times New Roman", Times, serif;"></td> <td style="width: 0.5in; vertical-align: top; overflow-wrap: break-word; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;">(B)</div></div> </td> <td style="text-align: justify; vertical-align: top; overflow-wrap: break-word; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"> <div style="font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;">On January 17, 2024, the Company entered into a convertible promissory note with 1800 Diagonal Lending, LLC with the principal amount of $65,000<div style="letter-spacing: 0px; top: 0px;display:inline;">, </div>maturity date November 30, 2024<div style="letter-spacing: 0px; top: 0px;display:inline;">, and</div> interest at<div style="letter-spacing: 0px; top: 0px;display:inline;"> </div><div style="letter-spacing: 0px; top: 0px;display:inline;">a<div style="letter-spacing: 0px; top: 0px;display:inline;"> </div></div>rate of 12% per annum. The note <div style="letter-spacing: 0px; top: 0px;display:inline;">includes a</div> conversion discount of 35 % and the conversion price shall be determined on the basis of the average of three lowest trading price of Common stock during the ten trading days period and is limited to convert no more than 4.99% of the issued and outstanding Common Stock at time of conversion at any one time.</div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;"></div> <div style="margin: 0in 0in 0.0001pt; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; white-space: pre-wrap; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;white-space:pre-wrap;"> </div></div> <div style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"></div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; color: rgb(0, 0, 0); line-height: 12pt; letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px;display:inline;">The total interest expense and accrued expense on the 1800 Diagonal Lending promissory note was</div></div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"> $919 </div><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; line-height: 12pt; letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;">for the year ended February 28, 2024.</div></div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;"></div></div> <div style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; white-space: pre-wrap; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;white-space:pre-wrap;"> </div></div> <div style="margin: 0in 0in 0.0001pt 0.5in; text-align: justify; line-height: 12pt; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;text-indent: 0px;display:inline;">As of February 28, 2024 and 2023 the balances of convertible notes payable were $766,419 and $594,804 respectively.</div><br/></div>
CY2024	bfyw	Gain Loss On Extinguishment Of Debt GainLossOnExtinguishmentOfDebt	80914
CY2024Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	766419
CY2023Q1	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	594804
CY2024Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2323
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2323
CY2024Q1	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	4869
CY2023Q1	us-gaap	Property Plant And Equipment Owned Accumulated Depreciation PropertyPlantAndEquipmentOwnedAccumulatedDepreciation	0
CY2024Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1932
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	776
CY2024Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	5260
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1547
CY2024	us-gaap	Depreciation Depreciation	1156
CY2023	us-gaap	Depreciation Depreciation	776
CY2024	bfyw	Rental Payments RentalPayments	6650
CY2023Q2	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	200215
CY2023Q2	bfyw	Treasury Rate TreasuryRate	0.12
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	79800
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	79800
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	6650
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	166250
CY2024Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	19796
CY2024Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	146454
CY2024Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	65765
CY2024Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	80689
CY2024	bfyw	Schedule Of Additional Information Pertaining To Our Leases ScheduleOfAdditionalInformationPertainingToOurLeases	<div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: justify; font-family: "Times New Roman", Times, serif; line-height: 12pt;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, serif; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">The following table set forth additional information pertaining to our leases:</div><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div><div style="margin: 0in 0in 0.0001pt; text-align: justify; font-family: "Times New Roman", Times, serif; font-size: 10pt; line-height: 12pt;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, serif; white-space: pre-wrap; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;white-space:pre-wrap;"> </div></div></div><table cellpadding="0" cellspacing="0" style="text-align:start; width: 93%; border-collapse: collapse; text-indent: 0px; border-spacing: 0px; margin: 0in 0in 0in 0.5in;margin-right : auto;"><tr><td style="width: 87%; padding: 0px 0in 0.5pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; vertical-align: bottom; border-bottom: 0.75pt solid black;"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; text-align: left;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">For the twelve months ending February 28,</div></div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="padding: 0in 0in 0.5pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; vertical-align: bottom;"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; text-align: center;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td colspan="2" style="padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-bottom: 1pt solid windowtext; white-space: nowrap; vertical-align: bottom; width: 11%;"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: center; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="white-space: nowrap;font-weight:bold;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;">2024</div></div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"></div></div></div></td><td style="padding: 0in 0in 0.5pt; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; vertical-align: bottom;"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: center; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"> </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"></div></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;background-color:rgb(204, 238, 255);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: justify; font-family: "Times New Roman", Times, "serif"; line-height: 12pt;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">Cash paid for amounts included in the measurement of lease liabilities:</div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="width: 1%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;background-color:rgb(204, 238, 255);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: justify; font-family: "Times New Roman", Times, "serif"; line-height: 12pt;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="width: 1%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); border-top: 0px solid windowtext; text-align: left; vertical-align: bottom;background-color:rgb(204, 238, 255);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: left; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; text-indent: 0in; white-space: nowrap;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="width: 10%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; border-top: 0px solid windowtext; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;background-color:rgb(204, 238, 255);"><div style="margin: 0in 0in 0.0001pt; text-align: right; font-family: "Times New Roman", Times, "serif"; font-size: 10pt; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;">6,650</div></div><div style="white-space: nowrap; font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; white-space: nowrap; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;white-space:pre-wrap;"></div></div></div></td><td style="width: 1%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;background-color:rgba(255, 255, 255, 0);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: justify; font-family: "Times New Roman", Times, "serif"; line-height: 12pt;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">Operating cash flows from operating leases</div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="width: 1%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;background-color:rgba(255, 255, 255, 0);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: justify; font-family: "Times New Roman", Times, "serif"; line-height: 12pt;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="width: 1%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;background-color:rgba(255, 255, 255, 0);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: left; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; text-indent: 0in; white-space: nowrap;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="width: 10%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;background-color:rgba(255, 255, 255, 0);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: right; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;">13,300</div></div><div style="white-space: nowrap; font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; white-space: nowrap; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;white-space:pre-wrap;"></div></div></div></td><td style="width: 1%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;background-color:rgb(204, 238, 255);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: justify; font-family: "Times New Roman", Times, "serif"; line-height: 12pt;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">Weighted average remaining lease term – operating leases</div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="width: 1%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;background-color:rgb(204, 238, 255);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: justify; font-family: "Times New Roman", Times, "serif"; line-height: 12pt;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="width: 1%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;background-color:rgb(204, 238, 255);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: left; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; text-indent: 0in; white-space: nowrap;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="width: 10.42%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); vertical-align: bottom;background-color:rgb(204, 238, 255);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: right; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;">2 years</div></div></div></td><td style="width: 1%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap; line-height: normal;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"></div></div></td></tr><tr><td style="width: 87%; padding: 0px 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;background-color:rgba(255, 255, 255, 0);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: justify; font-family: "Times New Roman", Times, "serif"; line-height: 12pt;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;">Weighted average discount rate – operating leases</div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="width: 1%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;background-color:rgba(255, 255, 255, 0);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: justify; font-family: "Times New Roman", Times, "serif"; line-height: 12pt;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="width: 1%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;background-color:rgba(255, 255, 255, 0);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: left; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; text-indent: 0in; white-space: nowrap;"><div style="font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px;display:inline;"> </div><div style="font-size: 10pt; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;display:inline;"></div></div></div></td><td style="width: 10%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom;background-color:rgba(255, 255, 255, 0);"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: right; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; white-space: nowrap;"><div style="white-space: nowrap; font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;">12</div></div><div style="white-space: nowrap; font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"></div></div></div></td><td style="width: 1%; padding: 0in; font-family: "Times New Roman", Times, serif; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom;"><div style="font-size: 10pt; margin: 0in 0in 0.0001pt; text-align: left; font-family: "Times New Roman", Times, "serif"; line-height: 12pt; white-space: nowrap; text-indent: 0in;"><div style="white-space: nowrap; font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;"></div></div><div style="white-space: nowrap; font-family: "Times New Roman", Times, "serif"; font-size: 10pt; letter-spacing: 0px; top: 0px;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: "Times New Roman", Times, "serif"; line-height: 12pt; letter-spacing: 0px; top: 0px; white-space: nowrap;display:inline;">%</div></div></div></td></tr></table>
CY2024	us-gaap	Operating Lease Payments OperatingLeasePayments	6650
CY2024	us-gaap	Proceeds From Operating Activities ProceedsFromOperatingActivities	13300
CY2024Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y
CY2024Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.12
CY2024Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	601487
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	393777
CY2024Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	85823
CY2023Q1	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	379759
CY2024	bfyw	Stock Purchase Warrant Liability Description StockPurchaseWarrantLiabilityDescription	On April 18, 2022, we entered into a Standby Equity Commitment Agreement with MacRab LLC, a Florida limited liability company providing us with an option to sell up to $5,000,000 worth of our Common Stock, par value $0.0001, to MacRab LLC, in increments, over the period ending 24 months after the date that the Company’s registration statement is deemed effective by the U.S. Securities and Exchange Commission, pursuant to the terms and conditions contained in the SECA. Additionally, we issued MacRab LLC a Common Stock purchase warrant for the purchase of 1,785,714 shares of our common stock as a commitment fee in connection with the execution of the Standby Equity Commitment Agreement. We also entered into a Registration Rights Agreement with the Investor requiring the Company to file a registration statement providing for the registration of the Common Stock issuable to MacRab LLC under the Standby Equity Commitment Agreement and their common stock purchase warrant, and the subsequent resale by MacRab LLC of such Common Stock.
CY2022Q2	us-gaap	Debt Instrument Fee Amount DebtInstrumentFeeAmount	22320
CY2024	bfyw	Non Cancelable Warrants Percentage NonCancelableWarrantsPercentage	0.08
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	1.20
CY2024Q1	us-gaap	Warrants And Rights Outstanding Term WarrantsAndRightsOutstandingTerm	P5Y
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000
CY2024Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	700000
CY2024Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	700000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	2000000000
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	419509183
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	419509183
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	404014987
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	404014987
CY2024Q1	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	2528230
CY2022Q2	us-gaap	Significant Purchase Commitment Description SignificantPurchaseCommitmentDescription	On April 12, 2022, the Company entered into a Securities Purchase Agreement with Mast Hill Fund, L.P., in which Mast Hill purchased a promissory note with a principal amount of $310,000 for a purchase price of $279,000 (the "Note"). The closing of the Purchase Agreements occurred on April 12, 2022. The Note bears an original issue discount of $31,000, and interest of 12% per year and matures on April 12, 2023 (the "Maturity Date"). The Note is convertible into shares of the Company's common stock at conversion price of $0.037 per share, subject to adjustment as provided therein.
CY2022Q2	us-gaap	Investment Owned Underlying Face Amount At Market Value InvestmentOwnedUnderlyingFaceAmountAtMarketValue	310000
CY2022Q2	us-gaap	Supplemental Deferred Purchase Price SupplementalDeferredPurchasePrice	279000
CY2022Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	31000
CY2022Q2	srt	Interest Bearing Liabilities Average Rate Paid InterestBearingLiabilitiesAverageRatePaid	0.12
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	0.037
CY2024	bfyw	Purchase Commitment Shares PurchaseCommitmentShares	4960000
CY2022Q3	us-gaap	Capital Units Outstanding CapitalUnitsOutstanding	78.32
CY2022Q4	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	2686667
CY2022Q4	bfyw	Extension Value ExtensionValue	64211
CY2022Q4	bfyw	Authorized The Issuance Of Common Shares AuthorizedTheIssuanceOfCommonShares	760780
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	17500
CY2022Q4	us-gaap	Partners Capital PartnersCapital	17500
CY2022Q4	us-gaap	Shares Issued SharesIssued	1250000
CY2022Q4	bfyw	Consideration Amount ConsiderationAmount	30000
CY2024	us-gaap	Conversion Of Stock Description ConversionOfStockDescription	Aprari Solutions will be paid $25,000 over 12 months for accounting and auditing assistance services and for fractional CFO services, $30,000 in cash, and $10,000 in stock over 12 months.
CY2024Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	300000
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	20000000
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Accelerated Vesting Number SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber	14000000
CY2024	bfyw	Stock Option Description StockOptionDescription	6,000,000 shares were fully vested during the current year
CY2024Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	25
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0101
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0126
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2024	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.72
CY2022Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1.63
CY2024Q1	us-gaap	Share Price SharePrice	0.22
CY2022Q1	us-gaap	Share Price SharePrice	0.11
CY2024	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	4445628
CY2022Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	408121
CY2024	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	614614
CY2023	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	1241373
CY2024	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001575872-24-000990-index-headers.html	Edgar Link	pending
0001575872-24-000990-index.html	Edgar Link	pending
0001575872-24-000990.txt	Edgar Link	pending
0001575872-24-000990-xbrl.zip	Edgar Link	pending
bf064-ex21-1.htm	Edgar Link	pending
bf064_ex31-1.htm	Edgar Link	pending
bf064_ex31-2.htm	Edgar Link	pending
bf064_ex32.htm	Edgar Link	pending
bfyw-20240228.htm	Edgar Link	pending
bfyw-20240228.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
bfyw-20240228_def.xml	Edgar Link	unprocessable
bfyw-20240228_lab.xml	Edgar Link	unprocessable
bfyw-20240228_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
bfyw-20240228_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bfyw-20240228_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BFYW
Better For You Wellness, Inc. Stock $bfyw

2024 Q3 Form 10-K Financial Statement

#000157587224000990 Filed on September 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BFYW Better For You Wellness, Inc. Stock $bfyw

2024 Q3 Form 10-K Financial Statement

#000157587224000990 Filed on September 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BFYW
Better For You Wellness, Inc. Stock $bfyw